REGULATORY

MHLW to Set Generic Share Target of 80% by FY2020-End: Shiozaki

May 27, 2015

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Ministry of Health, Labor and Welfare (MHLW) will set a new volume-based generic share target of 80% by the end of FY2020, while moving up the FY2017 deadline for the current 60% goal by one year, Health Minister Yasuhisa…

To read the full story

Japan Cabinet OKs Fiscal Policy Guidelines, Marking Dawn of “80% Generic” Era
July 1, 2015
80% Generic Share “at Early Date,” Essential Drug Supplies Join Draft Fiscal Policy Blueprint
June 23, 2015
MOF Generic Target, Reference Pricing Rollout “Impossible”: LDP Panel
June 19, 2015

REGULATORY

MHLW Revises Biological Raw Material Rules, Clarifies Donor Testing Flexibility
April 2, 2026
Japan Officially Eases Trial Recruitment Rules; Industry Welcomes Move
April 1, 2026
MHLW Updates Q&A on Use of Registry Data in Drug Applications
April 1, 2026
Japan Panel Designates Two Ebola Therapies for Early Approval Pathway
April 1, 2026
MHLW, METI Launch Joint Task Force to Safeguard Medical Supply Chains
April 1, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…